Literature DB >> 2831603

Refractory neonatal hypoxemia: diagnostic evaluation and pharmacologic management.

W E Benitz1, D K Stevenson.   

Abstract

Hypoxemia refractory to oxygen administration and assisted ventilation is found in many clinical conditions and results from a variety of pathophysiologic disorders. Recent clinical and laboratory experience has demonstrated that the choice of therapy for an infant with refractory hypoxemia depends upon identification of the underlying etiologic and pathophysiologic conditions. The ideal therapies for many of these conditions have not yet been defined. We have provided, based on our experience, guidelines for selection of the most appropriate of the currently available therapies for many of these patients.

Entities:  

Mesh:

Year:  1988        PMID: 2831603     DOI: 10.1016/0300-9572(88)90018-4

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  6 in total

1.  Heart transplantation in children with mitochondrial cardiomyopathy.

Authors:  D Bonnet; P Rustin; A Rötig; J Le Bidois; A Munnich; P Vouhé; J Kachaner; D Sidi
Journal:  Heart       Date:  2001-11       Impact factor: 5.994

2.  Sedation by physician with diazepam for DC cardioversion of atrial arrhythmias.

Authors:  P J Pugh; P Spurrell; K Kamalvand; A N Sulke
Journal:  Heart       Date:  2001-11       Impact factor: 5.994

3.  Role of conscious sedation for external cardioversion.

Authors:  R Raipancholia; L Sentinella; M Lynch
Journal:  Heart       Date:  2001-11       Impact factor: 5.994

4.  Effect of circadian rhythm on response to carotid sinus massage.

Authors:  Y Atmaca; A Alpman; M Kilickap; S Murat; D Oral
Journal:  Heart       Date:  2001-11       Impact factor: 5.994

Review 5.  Treatment of newborn infants with inhaled nitric oxide.

Authors:  R H Mupanemunda; A D Edwards
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-03       Impact factor: 5.747

Review 6.  Nitric oxide.

Authors:  A D Milner
Journal:  Eur J Pediatr       Date:  1994       Impact factor: 3.183

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.